Safety and Privacy

​​​​​​Yes, participants are often provided with a summary of the trial’s results after the study concludes. You can ask the study team about how and when you will receive this information.

​​​Contributing to research that supports potentially more effective treatments that address the root causes of illnesses linked to somatic dysfunction—an impairment or alteration in the musculoskeletal, nervous, and lymphatic systems. These treatments offer potential as low-cost, noninvasive alternatives for future patient care.

Experiencing side effects of treatments including mild soreness for a brief 24-hour period post-intervention, like the effects experienced after a workout session. In some cases, the treatment might not be as effective as anticipated. However, your health and safety will be closely monitored throughout the trial.

Any unintended or harmful reactions that occur as a result of intervention in the clinical trial. Whether serious or mild, researchers will closely monitor and manage effects at all times.

An Institutional Review Board (IRB) is a committee of experts who review and monitor research studies to ensure the safety, rights, and welfare of participants. 

Your personal information and medical data will be kept confidential and protected according to federal privacy laws. Only authorized researchers will have access to your data, which will be anonymized in reports or publications. 

Your safety is our highest priority. The research team and the IRB closely monitor the study to address any risks as soon as they arise. We will frequently check for adverse effects and can withdraw from the study at any time.